This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

XIN JIANG READY HEALTH INDUSTRY Valuation

Is 600090 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 600090 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 600090's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 600090's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 600090?

Key metric: As 600090 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for 600090. This is calculated by dividing 600090's market cap by their current book value.
What is 600090's PB Ratio?
PB Ratio	0.1x
Book	CN¥3.79b
Market Cap	CN¥388.65m

600090 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	-1.4x
Enterprise Value/EBITDA	-1.2x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does 600090's PB Ratio compare to its peers?

The above table shows the PB ratio for 600090 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	1.5x
002589 Realcan Pharmaceutical Group	0.9x	n/a	CN¥4.8b
603122 Cowealth Medical ChinaLtd	2.5x	n/a	CN¥2.9b
301166 Shanghai Universal BiotechLtd	1.3x	n/a	CN¥2.7b
000705 Zhejiang Zhenyuan ShareLtd	1.4x	n/a	CN¥2.7b
600090 XIN JIANG READY HEALTH INDUSTRY	0.1x	n/a	CN¥388.6m

Price-To-Book vs Peers: 600090 is good value based on its Price-To-Book Ratio (0.1x) compared to the peer average (1.5x).

Price to Book Ratio vs Industry

How does 600090's PB Ratio compare vs other companies in the CN Healthcare Industry?

1 Company	Price / Book	Estimated Growth	Market Cap
Industry Avg.	2.1x	22.9%
600090 XIN JIANG READY HEALTH INDUSTRY	0.1x	n/a	US$58.00m

No more companies available in this PB range

1 Company		Estimated Growth	Market Cap
Industry Avg.	2.1x	22.9%
600090 XIN JIANG READY HEALTH INDUSTRY	0.1x	n/a	US$58.00m

No more companies

Price-To-Book vs Industry: 600090 is good value based on its Price-To-Book Ratio (0.1x) compared to the CN Healthcare industry average (2.1x)

Price to Book Ratio vs Fair Ratio

What is 600090's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

600090 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	0.1x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate 600090's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.1b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.65

-4.6%

-27.1%

Truking Technology

CN¥4.6b

Engages in medical equipment business in China and internationally.

300358

CN¥7.76

-3.8%

-35.3%

iRay Technology

CN¥16.4b

Develops, manufactures, and sells flat panel X-ray detectors for use in medical, dental, oncology, veterinary, security, and industrial imaging applications in China and internationally.

688301

CN¥114.87

-10.7%

-32.1%